Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
3
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
3
×
biotech
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
drugs
eli lilly
indiana blog main
indiana top stories
national
pfizer
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abiraterone
ac immune
acorda therapeutics
aduro biotech
agenus
akcea therapeutics
alder biopharmaceutical
aldeyra therapeutics
aleksandra rizo
What
drug
3
×
year
3
×
companies
fda
therapies
ago
akcea
alnylam
alzheimer’s
amyloidosis
approval
approved
arguments
attr
available
battle
big
bio
class
commercialized
competitors
debilitating
decades
different
disease
drugs
fail
gene
genetic
increases
latest
make
medicines
meeting
migraine
neuro
new
oks
oral
patients
Language
Current search:
drug
×
year
×
" san diego top stories "
×
" boston top stories "
×
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More